Physiopathology of necrobiotic xanthogranuloma with monoclonal gammopathy

Rationale Xanthomatosis associated with monoclonal gammopathy includes hyperlipidaemic xanthoma (HX), normolipidaemic xanthoma (NX) and necrobiotic xanthogranuloma (NXG). All three pathologies are characterized by skin or visceral lesions related to cholesterol accumulation, monoclonal immunoglobuli...

Full description

Saved in:
Bibliographic Details
Published inJournal of internal medicine Vol. 276; no. 3; pp. 269 - 284
Main Authors Szalat, R., Pirault, J., Fermand, J.‐P., Carrié, A., Saint‐Charles, F., Olivier, M., Robillard, P., Frisdal, E., Villard, E. F., Cathébras, P., Bruckert, E., Chapman, M. John, Giral, P., Guerin, M., Lesnik, P., Goff, W. Le
Format Journal Article
LanguageEnglish
Published England Wiley 01.09.2014
BlackWell Publishing Ltd
Subjects
Online AccessGet full text
ISSN0954-6820
1365-2796
1365-2796
DOI10.1111/joim.12195

Cover

Abstract Rationale Xanthomatosis associated with monoclonal gammopathy includes hyperlipidaemic xanthoma (HX), normolipidaemic xanthoma (NX) and necrobiotic xanthogranuloma (NXG). All three pathologies are characterized by skin or visceral lesions related to cholesterol accumulation, monoclonal immunoglobulin (MIg) and hypocomplementemia. The pathophysiology underlying NXG remains unknown although the involvement of MIg is suspected. Objective To provide further insights into the pathophysiology of NXG, we evaluated the plasma lipid phenotype, mechanisms involved in cellular cholesterol accumulation and role of MIg in an analysis of blood and plasma markers of inflammation in 16 patients with xanthomatosis [NXG (n = 8) and NX (n = 8)] associated with monoclonal IgG relative to the relevant controls. Results The lipid profile of patients with NXG was characterized by a low HDL‐C phenotype and an abnormal distribution of HDL particles. Sera from patients with NXG induced cholesterol accumulation in human macrophages. This accumulation was due in part to a significant reduction in the HDL capacity to promote cholesterol efflux from macrophages, which was not found in the case of NX. The MIg of NXG and NX patients was tested positively by ELISA to recognize a large spectrum of lipoproteins. High plasma levels of pro‐inflammatory cytokines (TNFα and IL‐6), soluble cytokine receptors (sIL‐6R, sTNFRI and sTNFRII), adhesion molecules (VCAM‐1 and ICAM‐1) and chemokines (MCP‐1, IL‐8 and MIP‐1α) were observed in both patients with NXG and NX, revealing a specific xanthoma inflammatory signature which was inversely correlated with plasma levels of anti‐inflammatory HDL. However, patients with NXG were distinguished by elevated levels of IL‐15 and a marked increase in the rate of intermediate CD14++CD16+ monocytes. Conclusion This study revealed that NXG is characterized by impaired macrophage lipid homeostasis associated with a systemic inflammatory profile that may result from the interaction of MIg and lipoproteins.
AbstractList Xanthomatosis associated with monoclonal gammopathy includes hyperlipidaemic xanthoma (HX), normolipidaemic xanthoma (NX) and necrobiotic xanthogranuloma (NXG). All three pathologies are characterized by skin or visceral lesions related to cholesterol accumulation, monoclonal immunoglobulin (MIg) and hypocomplementemia. The pathophysiology underlying NXG remains unknown although the involvement of MIg is suspected. To provide further insights into the pathophysiology of NXG, we evaluated the plasma lipid phenotype, mechanisms involved in cellular cholesterol accumulation and role of MIg in an analysis of blood and plasma markers of inflammation in 16 patients with xanthomatosis [NXG (n = 8) and NX (n = 8)] associated with monoclonal IgG relative to the relevant controls. The lipid profile of patients with NXG was characterized by a low HDL-C phenotype and an abnormal distribution of HDL particles. Sera from patients with NXG induced cholesterol accumulation in human macrophages. This accumulation was due in part to a significant reduction in the HDL capacity to promote cholesterol efflux from macrophages, which was not found in the case of NX. The MIg of NXG and NX patients was tested positively by ELISA to recognize a large spectrum of lipoproteins. High plasma levels of pro-inflammatory cytokines (TNFα and IL-6), soluble cytokine receptors (sIL-6R, sTNFRI and sTNFRII), adhesion molecules (VCAM-1 and ICAM-1) and chemokines (MCP-1, IL-8 and MIP-1α) were observed in both patients with NXG and NX, revealing a specific xanthoma inflammatory signature which was inversely correlated with plasma levels of anti-inflammatory HDL. However, patients with NXG were distinguished by elevated levels of IL-15 and a marked increase in the rate of intermediate CD14++CD16+ monocytes. This study revealed that NXG is characterized by impaired macrophage lipid homeostasis associated with a systemic inflammatory profile that may result from the interaction of MIg and lipoproteins.
Rationale Xanthomatosis associated with monoclonal gammopathy includes hyperlipidaemic xanthoma (HX), normolipidaemic xanthoma (NX) and necrobiotic xanthogranuloma (NXG). All three pathologies are characterized by skin or visceral lesions related to cholesterol accumulation, monoclonal immunoglobulin (MIg) and hypocomplementemia. The pathophysiology underlying NXG remains unknown although the involvement of MIg is suspected. Objective To provide further insights into the pathophysiology of NXG, we evaluated the plasma lipid phenotype, mechanisms involved in cellular cholesterol accumulation and role of MIg in an analysis of blood and plasma markers of inflammation in 16 patients with xanthomatosis [NXG (n = 8) and NX (n = 8)] associated with monoclonal IgG relative to the relevant controls. Results The lipid profile of patients with NXG was characterized by a low HDL‐C phenotype and an abnormal distribution of HDL particles. Sera from patients with NXG induced cholesterol accumulation in human macrophages. This accumulation was due in part to a significant reduction in the HDL capacity to promote cholesterol efflux from macrophages, which was not found in the case of NX. The MIg of NXG and NX patients was tested positively by ELISA to recognize a large spectrum of lipoproteins. High plasma levels of pro‐inflammatory cytokines (TNFα and IL‐6), soluble cytokine receptors (sIL‐6R, sTNFRI and sTNFRII), adhesion molecules (VCAM‐1 and ICAM‐1) and chemokines (MCP‐1, IL‐8 and MIP‐1α) were observed in both patients with NXG and NX, revealing a specific xanthoma inflammatory signature which was inversely correlated with plasma levels of anti‐inflammatory HDL. However, patients with NXG were distinguished by elevated levels of IL‐15 and a marked increase in the rate of intermediate CD14++CD16+ monocytes. Conclusion This study revealed that NXG is characterized by impaired macrophage lipid homeostasis associated with a systemic inflammatory profile that may result from the interaction of MIg and lipoproteins.
Xanthomatosis associated with monoclonal gammopathy includes hyperlipidaemic xanthoma (HX), normolipidaemic xanthoma (NX) and necrobiotic xanthogranuloma (NXG). All three pathologies are characterized by skin or visceral lesions related to cholesterol accumulation, monoclonal immunoglobulin (MIg) and hypocomplementemia. The pathophysiology underlying NXG remains unknown although the involvement of MIg is suspected.RATIONALEXanthomatosis associated with monoclonal gammopathy includes hyperlipidaemic xanthoma (HX), normolipidaemic xanthoma (NX) and necrobiotic xanthogranuloma (NXG). All three pathologies are characterized by skin or visceral lesions related to cholesterol accumulation, monoclonal immunoglobulin (MIg) and hypocomplementemia. The pathophysiology underlying NXG remains unknown although the involvement of MIg is suspected.To provide further insights into the pathophysiology of NXG, we evaluated the plasma lipid phenotype, mechanisms involved in cellular cholesterol accumulation and role of MIg in an analysis of blood and plasma markers of inflammation in 16 patients with xanthomatosis [NXG (n = 8) and NX (n = 8)] associated with monoclonal IgG relative to the relevant controls.OBJECTIVETo provide further insights into the pathophysiology of NXG, we evaluated the plasma lipid phenotype, mechanisms involved in cellular cholesterol accumulation and role of MIg in an analysis of blood and plasma markers of inflammation in 16 patients with xanthomatosis [NXG (n = 8) and NX (n = 8)] associated with monoclonal IgG relative to the relevant controls.The lipid profile of patients with NXG was characterized by a low HDL-C phenotype and an abnormal distribution of HDL particles. Sera from patients with NXG induced cholesterol accumulation in human macrophages. This accumulation was due in part to a significant reduction in the HDL capacity to promote cholesterol efflux from macrophages, which was not found in the case of NX. The MIg of NXG and NX patients was tested positively by ELISA to recognize a large spectrum of lipoproteins. High plasma levels of pro-inflammatory cytokines (TNFα and IL-6), soluble cytokine receptors (sIL-6R, sTNFRI and sTNFRII), adhesion molecules (VCAM-1 and ICAM-1) and chemokines (MCP-1, IL-8 and MIP-1α) were observed in both patients with NXG and NX, revealing a specific xanthoma inflammatory signature which was inversely correlated with plasma levels of anti-inflammatory HDL. However, patients with NXG were distinguished by elevated levels of IL-15 and a marked increase in the rate of intermediate CD14++CD16+ monocytes.RESULTSThe lipid profile of patients with NXG was characterized by a low HDL-C phenotype and an abnormal distribution of HDL particles. Sera from patients with NXG induced cholesterol accumulation in human macrophages. This accumulation was due in part to a significant reduction in the HDL capacity to promote cholesterol efflux from macrophages, which was not found in the case of NX. The MIg of NXG and NX patients was tested positively by ELISA to recognize a large spectrum of lipoproteins. High plasma levels of pro-inflammatory cytokines (TNFα and IL-6), soluble cytokine receptors (sIL-6R, sTNFRI and sTNFRII), adhesion molecules (VCAM-1 and ICAM-1) and chemokines (MCP-1, IL-8 and MIP-1α) were observed in both patients with NXG and NX, revealing a specific xanthoma inflammatory signature which was inversely correlated with plasma levels of anti-inflammatory HDL. However, patients with NXG were distinguished by elevated levels of IL-15 and a marked increase in the rate of intermediate CD14++CD16+ monocytes.This study revealed that NXG is characterized by impaired macrophage lipid homeostasis associated with a systemic inflammatory profile that may result from the interaction of MIg and lipoproteins.CONCLUSIONThis study revealed that NXG is characterized by impaired macrophage lipid homeostasis associated with a systemic inflammatory profile that may result from the interaction of MIg and lipoproteins.
Author Saint‐Charles, F.
Robillard, P.
Chapman, M. John
Giral, P.
Guerin, M.
Frisdal, E.
Cathébras, P.
Goff, W. Le
Szalat, R.
Fermand, J.‐P.
Bruckert, E.
Olivier, M.
Lesnik, P.
Pirault, J.
Villard, E. F.
Carrié, A.
Author_xml – sequence: 1
  givenname: R.
  surname: Szalat
  fullname: Szalat, R.
  organization: Institut Universitaire d'Hématologie
– sequence: 2
  givenname: J.
  surname: Pirault
  fullname: Pirault, J.
  organization: Institute of Cardiometabolism and Nutrition (ICAN)
– sequence: 3
  givenname: J.‐P.
  surname: Fermand
  fullname: Fermand, J.‐P.
  organization: Institut Universitaire d'Hématologie
– sequence: 4
  givenname: A.
  surname: Carrié
  fullname: Carrié, A.
  organization: Hôpital Pitié‐Salpêtrière
– sequence: 5
  givenname: F.
  surname: Saint‐Charles
  fullname: Saint‐Charles, F.
  organization: Institute of Cardiometabolism and Nutrition (ICAN)
– sequence: 6
  givenname: M.
  surname: Olivier
  fullname: Olivier, M.
  organization: Institute of Cardiometabolism and Nutrition (ICAN)
– sequence: 7
  givenname: P.
  surname: Robillard
  fullname: Robillard, P.
  organization: Institute of Cardiometabolism and Nutrition (ICAN)
– sequence: 8
  givenname: E.
  surname: Frisdal
  fullname: Frisdal, E.
  organization: Institute of Cardiometabolism and Nutrition (ICAN)
– sequence: 9
  givenname: E. F.
  surname: Villard
  fullname: Villard, E. F.
  organization: Institute of Cardiometabolism and Nutrition (ICAN)
– sequence: 10
  givenname: P.
  surname: Cathébras
  fullname: Cathébras, P.
  organization: Service de médecine interne hôpital Nord
– sequence: 11
  givenname: E.
  surname: Bruckert
  fullname: Bruckert, E.
  organization: Hôpital Pitié‐Salpêtrière
– sequence: 12
  givenname: M. John
  surname: Chapman
  fullname: Chapman, M. John
  organization: Institute of Cardiometabolism and Nutrition (ICAN)
– sequence: 13
  givenname: P.
  surname: Giral
  fullname: Giral, P.
  organization: Hôpital Pitié‐Salpêtrière
– sequence: 14
  givenname: M.
  surname: Guerin
  fullname: Guerin, M.
  organization: Institute of Cardiometabolism and Nutrition (ICAN)
– sequence: 15
  givenname: P.
  surname: Lesnik
  fullname: Lesnik, P.
  organization: Institute of Cardiometabolism and Nutrition (ICAN)
– sequence: 16
  givenname: W. Le
  surname: Goff
  fullname: Goff, W. Le
  organization: Institute of Cardiometabolism and Nutrition (ICAN)
BackLink https://www.ncbi.nlm.nih.gov/pubmed/24428816$$D View this record in MEDLINE/PubMed
https://hal.science/hal-03624912$$DView record in HAL
BookMark eNp9kUFv1DAQhS3Uim4LF34AyhGQUmzHduwLUlUBXbSoHNqz5TjejSvHs8TZlvx7vE2LaIXwxbLne29Gb47RQYToEHpD8CnJ5-MN-P6UUKL4C7QgleAlrZU4QAusOCuFpPgIHad0gzGpsMAv0RFljEpJxAItf3RT8rA1YwcBNlMB6yI6O0DjYfS2-GVirmwGE3cBelPc-bEreohgA0QTio3p-3v19Aodrk1I7vXDfYKuv3y-Or8oV5dfl-dnq9JyynhpZMNFVde1bVshWYMtsdhZhmXjJHEVNzVXGaQtNUbh_CY1XtvGCCVbpkR1gj7Nvttd07vWujgOJujt4HszTBqM108r0Xd6A7ea5VQUk9ng_WzQPZNdnK30_g9XgjJF6C3J7LuHZgP83Lk06t4n60Iw0cEuacJ5RTBTqs7o27_n-uP8mHUG8AzkdFMa3FpbP5rRw35MHzTBer9OvV-nvl9nlnx4Jnl0_SdMZvjOBzf9h9TfLpffZ81vw9GxjA
CitedBy_id crossref_primary_10_1007_s00105_017_3995_3
crossref_primary_10_1016_j_mayocp_2021_05_012
crossref_primary_10_1177_2050313X211057929
crossref_primary_10_1007_s40620_021_01186_9
crossref_primary_10_1016_j_freeradbiomed_2015_08_010
crossref_primary_10_3324_haematol_2021_279118
crossref_primary_10_1111_dth_12744
crossref_primary_10_1161_ATVBAHA_118_310803
crossref_primary_10_1016_j_jdcr_2019_05_010
crossref_primary_10_1186_s13023_022_02291_z
crossref_primary_10_1016_S1761_2896_16_78236_7
crossref_primary_10_1016_j_jdcr_2023_07_024
crossref_primary_10_1111_jdv_13786
crossref_primary_10_1001_jamadermatol_2019_4221
crossref_primary_10_1002_acr_22843
crossref_primary_10_1002_acr_23316
crossref_primary_10_1007_s00105_016_3839_6
crossref_primary_10_1016_j_clml_2016_04_009
crossref_primary_10_5021_ad_2020_32_1_53
crossref_primary_10_1111_jdv_14213
crossref_primary_10_5045_br_2022_2022035
crossref_primary_10_1001_jamadermatol_2024_2921
crossref_primary_10_17116_otorino20248902182
crossref_primary_10_1093_ehjcr_ytad469
crossref_primary_10_3390_ijms25053011
crossref_primary_10_1111_jdv_13577
crossref_primary_10_36290_vnl_2021_092
crossref_primary_10_1016_j_jdcr_2022_12_002
Cites_doi 10.1056/NEJMoa054494
10.1016/j.cytogfr.2010.09.003
10.1016/j.ejcb.2010.11.005
10.1161/ATVBAHA.110.211342
10.1001/archinternmed.2009.551
10.1001/archderm.1986.01660230045008
10.1074/jbc.M111.264325
10.1097/MOL.0b013e328353ef07
10.1111/j.1365-4632.2009.03912.x
10.1016/j.tips.2011.09.004
10.1182/blood-2006-03-001164
10.1007/s00277-009-0849-9
10.1161/ATVBAHA.111.227181
10.1161/01.ATV.20.1.189
10.1136/jcp.56.1.64
10.1016/j.clim.2008.09.011
10.1194/jlr.M500255-JLR200
10.1161/01.RES.0000146094.59640.13
10.1189/jlb.0209082
10.1016/j.it.2011.05.005
10.1182/blood-2011-01-326827
10.4049/jimmunol.178.10.6581
10.1182/blood-2011-05-356907
10.1111/j.1346-8138.2006.00013.x
10.1016/j.jacc.2012.07.019
10.1093/eurheartj/ehq371
10.1586/erc.11.16
10.1016/S0021-9150(98)00260-3
10.1182/blood-2010-12-326355
10.1056/NEJMoa1001689
10.1172/JCI113960
10.1161/ATVBAHA.109.194548
10.1161/ATVBAHA.113.301468
ContentType Journal Article
Copyright 2014 The Authors. Journal of Internal Medicine published by John Wiley & Sons Ltd on behalf of The Association for the Publication of the Journal of Internal Medicine.
Distributed under a Creative Commons Attribution 4.0 International License
2014 The Authors. Journal of Internal Medicine published by John Wiley & Sons Ltd on behalf of The Association for the Publication of the Journal of Internal Medicine. 2014
Copyright_xml – notice: 2014 The Authors. Journal of Internal Medicine published by John Wiley & Sons Ltd on behalf of The Association for the Publication of the Journal of Internal Medicine.
– notice: Distributed under a Creative Commons Attribution 4.0 International License
– notice: 2014 The Authors. Journal of Internal Medicine published by John Wiley & Sons Ltd on behalf of The Association for the Publication of the Journal of Internal Medicine. 2014
DBID 24P
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
1XC
5PM
DOI 10.1111/joim.12195
DatabaseName Wiley Online Library Open Access
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
Hyper Article en Ligne (HAL)
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE

MEDLINE - Academic
Database_xml – sequence: 1
  dbid: 24P
  name: Wiley Online Library Open Access
  url: https://authorservices.wiley.com/open-science/open-access/browse-journals.html
  sourceTypes: Publisher
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1365-2796
EndPage 284
ExternalDocumentID PMC4279948
oai_HAL_hal_03624912v1
24428816
10_1111_joim_12195
JOIM12195
Genre article
Research Support, Non-U.S. Gov't
Journal Article
GrantInformation_xml – fundername: Fondation de France
– fundername: INSERM
– fundername: Région Ile‐de‐France CODDIM
GroupedDBID ---
.3N
.55
.GA
.GJ
.Y3
05W
0R~
10A
1OB
1OC
24P
29K
2WC
31~
33P
36B
3O-
3SF
4.4
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5GY
5HH
5LA
5RE
5VS
66C
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A01
A03
AAESR
AAEVG
AAHQN
AAIPD
AAMMB
AAMNL
AANHP
AANLZ
AAONW
AASGY
AAWTL
AAXRX
AAYCA
AAZKR
ABCQN
ABCUV
ABEML
ABJNI
ABLJU
ABOCM
ABPVW
ABQWH
ABXGK
ACAHQ
ACBWZ
ACCZN
ACGFO
ACGFS
ACGOF
ACMXC
ACPOU
ACPRK
ACRPL
ACSCC
ACXBN
ACXQS
ACYXJ
ADBBV
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADNMO
ADOZA
ADXAS
ADZMN
AEFGJ
AEGXH
AEIGN
AEIMD
AENEX
AEUYR
AEYWJ
AFBPY
AFEBI
AFFNX
AFFPM
AFGKR
AFRAH
AFWVQ
AFZJQ
AGHNM
AGQPQ
AGXDD
AGYGG
AHBTC
AHEFC
AI.
AIACR
AIAGR
AIDQK
AIDYY
AIQQE
AITYG
AIURR
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
ALVPJ
AMBMR
AMYDB
ATUGU
AZBYB
AZFZN
AZVAB
BAFTC
BAWUL
BDRZF
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
BY8
C45
CAG
COF
CS3
D-6
D-7
D-E
D-F
D-I
DCZOG
DIK
DPXWK
DR2
DRFUL
DRMAN
DRSTM
DU5
DUUFO
E3Z
EBS
EJD
EMOBN
EX3
F00
F01
F04
F5P
FEDTE
FIJ
FUBAC
G-S
G.N
GODZA
H.X
HF~
HGLYW
HVGLF
HZI
HZ~
IHE
IX1
J0M
KBYEO
LATKE
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
MEWTI
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N4W
N9A
NF~
O66
O9-
OIG
OK1
OVD
P2P
P2W
P2X
P2Z
P4B
P4D
PALCI
PQQKQ
Q.N
Q11
QB0
R.K
RIWAO
RJQFR
ROL
RX1
SAMSI
SJN
SUPJJ
TEORI
TR2
UB1
V8K
V9Y
VH1
VVN
W8V
W99
WBKPD
WH7
WHWMO
WIH
WIJ
WIK
WIN
WOHZO
WOW
WQJ
WVDHM
WXI
WXSBR
X7M
XG1
YFH
YOC
YUY
ZCG
ZGI
ZXP
ZZTAW
~IA
~WT
AAYXX
CITATION
AAHHS
ACCFJ
AEEZP
AEQDE
AEUQT
AFPWT
AIWBW
AJBDE
CGR
CUY
CVF
ECM
EIF
ESX
IPNFZ
NPM
PKN
WRC
WUP
7X8
1XC
5PM
ID FETCH-LOGICAL-c5245-a8b563777cdd684b0c1c0ec408be81e35a7592452d2aa9035a170fcba698d4963
IEDL.DBID DR2
ISSN 0954-6820
1365-2796
IngestDate Thu Aug 21 17:47:02 EDT 2025
Fri Sep 12 12:48:26 EDT 2025
Fri Jul 11 03:19:48 EDT 2025
Wed Feb 19 01:56:53 EST 2025
Thu Apr 24 23:10:59 EDT 2025
Wed Oct 01 01:20:25 EDT 2025
Sun Sep 21 06:21:41 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 3
Keywords HDL
monocyte
necrobiotic xanthogranuloma
monoclonal immunoglobulin
histiocytes
immune complex
Language English
License Attribution
http://creativecommons.org/licenses/by/3.0
2014 The Authors. Journal of Internal Medicine published by John Wiley & Sons Ltd on behalf of The Association for the Publication of the Journal of Internal Medicine.
Distributed under a Creative Commons Attribution 4.0 International License: http://creativecommons.org/licenses/by/4.0
This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c5245-a8b563777cdd684b0c1c0ec408be81e35a7592452d2aa9035a170fcba698d4963
Notes Drs. Raphael Szalat and John Pirault contributed equally to this work.
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMCID: PMC4279948
ORCID 0000-0001-7570-3366
0000-0003-0150-1360
OpenAccessLink https://proxy.k.utb.cz/login?url=https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fjoim.12195
PMID 24428816
PQID 1553104997
PQPubID 23479
PageCount 16
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_4279948
hal_primary_oai_HAL_hal_03624912v1
proquest_miscellaneous_1553104997
pubmed_primary_24428816
crossref_citationtrail_10_1111_joim_12195
crossref_primary_10_1111_joim_12195
wiley_primary_10_1111_joim_12195_JOIM12195
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate September 2014
PublicationDateYYYYMMDD 2014-09-01
PublicationDate_xml – month: 09
  year: 2014
  text: September 2014
PublicationDecade 2010
PublicationPlace England
PublicationPlace_xml – name: England
– name: Oxford, UK
PublicationTitle Journal of internal medicine
PublicationTitleAlternate J Intern Med
PublicationYear 2014
Publisher Wiley
BlackWell Publishing Ltd
Publisher_xml – name: Wiley
– name: BlackWell Publishing Ltd
References 2012; 60
1989; 83
2011; 118
2006; 33
2000; 20
1999; 142
2011; 31
2011; 32
2009; 130
2012; 33
2006; 354
2009; 48
2009; 29
2003; 56
2011; 9
2010; 89
1980; 39
2010; 87
2007; 178
2006; 108
2004; 95
2013; 33
1986; 122
2011; 90
2006; 47
2011; 22
2010; 170
2012; 23
2010; 30
2011; 364
2011; 286
e_1_2_9_30_1
e_1_2_9_31_1
e_1_2_9_11_1
e_1_2_9_34_1
e_1_2_9_35_1
e_1_2_9_13_1
e_1_2_9_32_1
e_1_2_9_12_1
e_1_2_9_33_1
e_1_2_9_15_1
e_1_2_9_14_1
e_1_2_9_17_1
e_1_2_9_16_1
e_1_2_9_19_1
e_1_2_9_18_1
e_1_2_9_20_1
e_1_2_9_22_1
e_1_2_9_21_1
e_1_2_9_24_1
e_1_2_9_23_1
e_1_2_9_8_1
e_1_2_9_7_1
e_1_2_9_6_1
e_1_2_9_5_1
e_1_2_9_4_1
e_1_2_9_3_1
e_1_2_9_2_1
Baudet MF (e_1_2_9_10_1) 1980; 39
e_1_2_9_9_1
e_1_2_9_26_1
e_1_2_9_25_1
e_1_2_9_28_1
e_1_2_9_27_1
e_1_2_9_29_1
21653326 - Blood. 2011 Aug 4;118(5):e16-31
20943670 - Eur Heart J. 2011 Jan;32(1):84-92
15486323 - Circ Res. 2004 Oct 15;95(8):764-72
20212186 - Arch Intern Med. 2010 Mar 8;170(5):478-84
22032984 - Trends Pharmacol Sci. 2012 Jan;33(1):35-41
3096220 - Arch Dermatol. 1986 Nov;122(11):1253-7
21074481 - Cytokine Growth Factor Rev. 2011 Feb;22(1):19-33
18952503 - Clin Immunol. 2009 Mar;130(3):338-46
21752713 - Trends Immunol. 2011 Aug;32(8):380-7
22510809 - Curr Opin Lipidol. 2012 Aug;23(4):377-85
21803849 - Blood. 2011 Sep 22;118(12):e50-61
2921322 - J Clin Invest. 1989 Mar;83(3):796-802
24092747 - Arterioscler Thromb Vasc Biol. 2013 Dec;33(12):2715-23
20702809 - Arterioscler Thromb Vasc Biol. 2010 Sep;30(9):1773-8
16469089 - J Dermatol. 2006 Jan;33(1):64-7
10634817 - Arterioscler Thromb Vasc Biol. 2000 Jan;20(1):189-97
6771077 - Clin Exp Immunol. 1980 Feb;39(2):455-60
21757618 - Blood. 2011 Oct 6;118(14):3777-84
21438812 - Expert Rev Cardiovasc Ther. 2011 Mar;9(3):329-40
21226578 - N Engl J Med. 2011 Jan 13;364(2):127-35
16215259 - J Lipid Res. 2006 Jan;47(1):51-8
19921193 - Ann Hematol. 2010 Jun;89(6):569-77
10030387 - Atherosclerosis. 1999 Feb;142(2):355-65
16794250 - Blood. 2006 Oct 15;108(8):2520-30
16571879 - N Engl J Med. 2006 Mar 30;354(13):1362-9
21194787 - Eur J Cell Biol. 2011 Jun-Jul;90(6-7):527-35
21757719 - J Biol Chem. 2011 Sep 2;286(35):30926-36
12499438 - J Clin Pathol. 2003 Jan;56(1):64-8
19126043 - Int J Dermatol. 2009 Jan;48(1):1-10
17475889 - J Immunol. 2007 May 15;178(10):6581-9
19843579 - J Leukoc Biol. 2010 Apr;87(4):557-67
22999728 - J Am Coll Cardiol. 2012 Oct 16;60(16):1512-20
21527752 - Arterioscler Thromb Vasc Biol. 2011 Jul;31(7):1675-81
19729607 - Arterioscler Thromb Vasc Biol. 2009 Nov;29(11):1930-6
References_xml – volume: 130
  start-page: 338
  year: 2009
  end-page: 46
  article-title: Enhanced frequencies of CD14++CD16+, but not CD14+CD16+, peripheral blood monocytes in severe asthmatic patients
  publication-title: Clin Immunol
– volume: 87
  start-page: 557
  year: 2010
  end-page: 67
  article-title: Monocyte heterogeneity underlying phenotypic changes in monocytes according to SIV disease stage
  publication-title: J Leukoc Biol
– volume: 39
  start-page: 455
  year: 1980
  end-page: 60
  article-title: Interaction between fibroblasts, lipoproteins and three antilipoproteins IgA kappa
  publication-title: Clin Exp Immunol
– volume: 142
  start-page: 355
  year: 1999
  end-page: 65
  article-title: Activation of monocytes causes intracellular accumulation of lipoprotein‐derived lipids and marked hypocholesterolemia–a possible pathogenesis of necrobiotic xanthogranuloma
  publication-title: Atherosclerosis
– volume: 178
  start-page: 6581
  year: 2007
  end-page: 9
  article-title: The CD16+ monocyte subset is more permissive to infection and preferentially harbors HIV‐1
  publication-title: J Immunol
– volume: 33
  start-page: 35
  year: 2012
  end-page: 41
  article-title: Interleukin‐15 biology and its therapeutic implications in cancer
  publication-title: Trends Pharmacol Sci
– volume: 90
  start-page: 527
  year: 2011
  end-page: 35
  article-title: The, “A Disintegrin And Metalloproteases” ADAM10 and ADAM17: novel drug targets with therapeutic potential?
  publication-title: Eur J Cell Biol
– volume: 122
  start-page: 1253
  year: 1986
  end-page: 7
  article-title: Normocholesterolemic xanthomatosis
  publication-title: Arch Dermatol
– volume: 83
  start-page: 796
  year: 1989
  end-page: 802
  article-title: Cutaneous xanthoma in association with paraproteinemia in the absence of hyperlipidemia
  publication-title: J Clin Invest
– volume: 29
  start-page: 1930
  year: 2009
  end-page: 6
  article-title: Stimulation of cholesterol efflux by LXR agonists in cholesterol‐loaded human macrophages is ABCA1‐dependent but ABCG1‐independent
  publication-title: Arterioscler Thromb Vasc Biol
– volume: 170
  start-page: 478
  year: 2010
  end-page: 84
  article-title: The metabolic syndrome, its component risk factors, and progression of coronary atherosclerosis
  publication-title: Arch Intern Med
– volume: 32
  start-page: 84
  year: 2011
  end-page: 92
  article-title: CD14++CD16+ monocytes and cardiovascular outcome in patients with chronic kidney disease
  publication-title: Eur Heart J
– volume: 108
  start-page: 2520
  year: 2006
  end-page: 30
  article-title: Dangerous small B‐cell clones
  publication-title: Blood
– volume: 95
  start-page: 764
  year: 2004
  end-page: 72
  article-title: Antiinflammatory properties of HDL
  publication-title: Circ Res
– volume: 23
  start-page: 377
  year: 2012
  end-page: 85
  article-title: Reverse cholesterol transport in familial hypercholesterolemia
  publication-title: Curr Opin Lipidol
– volume: 56
  start-page: 64
  year: 2003
  end-page: 8
  article-title: Clinical, biochemical, and immunohistochemical features of necrobiotic xanthogranulomatosis
  publication-title: J Clin Pathol
– volume: 9
  start-page: 329
  year: 2011
  end-page: 40
  article-title: Macrophage cholesterol homeostasis and metabolic diseases: critical role of cholesteryl ester mobilization
  publication-title: Expert Rev Cardiovasc Ther
– volume: 22
  start-page: 19
  year: 2011
  end-page: 33
  article-title: Role of IL‐15 in immune‐mediated and infectious diseases
  publication-title: Cytokine Growth Factor Rev
– volume: 60
  start-page: 1512
  year: 2012
  end-page: 20
  article-title: CD14++CD16+ monocytes independently predict cardiovascular events: a cohort study of 951 patients referred for elective coronary angiography
  publication-title: J Am Coll Cardiol
– volume: 364
  start-page: 127
  year: 2011
  end-page: 35
  article-title: Cholesterol efflux capacity, high‐density lipoprotein function, and atherosclerosis
  publication-title: N Engl J Med
– volume: 354
  start-page: 1362
  year: 2006
  end-page: 9
  article-title: Prevalence of monoclonal gammopathy of undetermined significance
  publication-title: N Engl J Med
– volume: 30
  start-page: 1773
  year: 2010
  end-page: 8
  article-title: High‐density lipoproteins suppress chemokines and chemokine receptors and
  publication-title: Arterioscler Thromb Vasc Biol
– volume: 33
  start-page: 2715
  year: 2013
  end-page: 23
  article-title: Small, dense high‐density lipoprotein‐3 particles are enriched in negatively charged phospholipids: relevance to cellular cholesterol efflux, antioxidative, antithrombotic, anti‐inflammatory, and antiapoptotic functionalities
  publication-title: Arterioscler Thromb Vasc Biol
– volume: 89
  start-page: 569
  year: 2010
  end-page: 77
  article-title: Hyperlipidemic myeloma: review of 53 cases
  publication-title: Ann Hematol
– volume: 118
  start-page: e50
  year: 2011
  end-page: 61
  article-title: SuperSAGE evidence for CD14++CD16+ monocytes as a third monocyte subset
  publication-title: Blood
– volume: 118
  start-page: 3777
  year: 2011
  end-page: 84
  article-title: Pathogenesis and treatment of xanthomatosis associated with monoclonal gammopathy
  publication-title: Blood
– volume: 286
  start-page: 30926
  year: 2011
  end-page: 36
  article-title: Interleukin‐6 protects human macrophages from cellular cholesterol accumulation and attenuates the proinflammatory response
  publication-title: J Biol Chem
– volume: 48
  start-page: 1
  year: 2009
  end-page: 10
  article-title: Necrobiotic xanthogranuloma
  publication-title: Int J Dermatol
– volume: 32
  start-page: 380
  year: 2011
  end-page: 7
  article-title: ADAM17: a molecular switch to control inflammation and tissue regeneration
  publication-title: Trends Immunol
– volume: 33
  start-page: 64
  year: 2006
  end-page: 7
  article-title: A case of diffuse plane normolipemic xanthomatosis associated with pancytopenia and monoclonal gammopathy
  publication-title: J Dermatol
– volume: 20
  start-page: 189
  year: 2000
  end-page: 97
  article-title: Action of atorvastatin in combined hyperlipidemia: preferential reduction of cholesteryl ester transfer from HDL to VLDL1 particles
  publication-title: Arterioscler Thromb Vasc Biol
– volume: 118
  start-page: e16
  year: 2011
  end-page: 31
  article-title: Gene expression profiling reveals the defining features of the classical, intermediate, and nonclassical human monocyte subsets
  publication-title: Blood
– volume: 31
  start-page: 1675
  year: 2011
  end-page: 81
  article-title: Atheroprotective reverse cholesterol transport pathway is defective in familial hypercholesterolemia
  publication-title: Arterioscler Thromb Vasc Biol
– volume: 47
  start-page: 51
  year: 2006
  end-page: 8
  article-title: Reevaluation of the role of the multidrug‐resistant P‐glycoprotein in cellular cholesterol homeostasis
  publication-title: J Lipid Res
– ident: e_1_2_9_2_1
  doi: 10.1056/NEJMoa054494
– ident: e_1_2_9_27_1
  doi: 10.1016/j.cytogfr.2010.09.003
– ident: e_1_2_9_22_1
  doi: 10.1016/j.ejcb.2010.11.005
– ident: e_1_2_9_24_1
  doi: 10.1161/ATVBAHA.110.211342
– ident: e_1_2_9_13_1
  doi: 10.1001/archinternmed.2009.551
– ident: e_1_2_9_4_1
  doi: 10.1001/archderm.1986.01660230045008
– ident: e_1_2_9_17_1
  doi: 10.1074/jbc.M111.264325
– ident: e_1_2_9_19_1
  doi: 10.1097/MOL.0b013e328353ef07
– ident: e_1_2_9_6_1
  doi: 10.1111/j.1365-4632.2009.03912.x
– ident: e_1_2_9_28_1
  doi: 10.1016/j.tips.2011.09.004
– ident: e_1_2_9_3_1
  doi: 10.1182/blood-2006-03-001164
– ident: e_1_2_9_8_1
  doi: 10.1007/s00277-009-0849-9
– ident: e_1_2_9_14_1
  doi: 10.1161/ATVBAHA.111.227181
– ident: e_1_2_9_15_1
  doi: 10.1161/01.ATV.20.1.189
– ident: e_1_2_9_11_1
  doi: 10.1136/jcp.56.1.64
– ident: e_1_2_9_31_1
  doi: 10.1016/j.clim.2008.09.011
– ident: e_1_2_9_16_1
  doi: 10.1194/jlr.M500255-JLR200
– ident: e_1_2_9_23_1
  doi: 10.1161/01.RES.0000146094.59640.13
– ident: e_1_2_9_32_1
  doi: 10.1189/jlb.0209082
– ident: e_1_2_9_26_1
  doi: 10.1016/j.it.2011.05.005
– ident: e_1_2_9_34_1
  doi: 10.1182/blood-2011-01-326827
– ident: e_1_2_9_33_1
  doi: 10.4049/jimmunol.178.10.6581
– ident: e_1_2_9_5_1
  doi: 10.1182/blood-2011-05-356907
– ident: e_1_2_9_9_1
  doi: 10.1111/j.1346-8138.2006.00013.x
– ident: e_1_2_9_29_1
  doi: 10.1016/j.jacc.2012.07.019
– ident: e_1_2_9_30_1
  doi: 10.1093/eurheartj/ehq371
– ident: e_1_2_9_21_1
  doi: 10.1586/erc.11.16
– volume: 39
  start-page: 455
  year: 1980
  ident: e_1_2_9_10_1
  article-title: Interaction between fibroblasts, lipoproteins and three antilipoproteins IgA kappa
  publication-title: Clin Exp Immunol
– ident: e_1_2_9_12_1
  doi: 10.1016/S0021-9150(98)00260-3
– ident: e_1_2_9_35_1
  doi: 10.1182/blood-2010-12-326355
– ident: e_1_2_9_20_1
  doi: 10.1056/NEJMoa1001689
– ident: e_1_2_9_7_1
  doi: 10.1172/JCI113960
– ident: e_1_2_9_18_1
  doi: 10.1161/ATVBAHA.109.194548
– ident: e_1_2_9_25_1
  doi: 10.1161/ATVBAHA.113.301468
– reference: 2921322 - J Clin Invest. 1989 Mar;83(3):796-802
– reference: 21438812 - Expert Rev Cardiovasc Ther. 2011 Mar;9(3):329-40
– reference: 15486323 - Circ Res. 2004 Oct 15;95(8):764-72
– reference: 16215259 - J Lipid Res. 2006 Jan;47(1):51-8
– reference: 22999728 - J Am Coll Cardiol. 2012 Oct 16;60(16):1512-20
– reference: 10030387 - Atherosclerosis. 1999 Feb;142(2):355-65
– reference: 22032984 - Trends Pharmacol Sci. 2012 Jan;33(1):35-41
– reference: 10634817 - Arterioscler Thromb Vasc Biol. 2000 Jan;20(1):189-97
– reference: 21074481 - Cytokine Growth Factor Rev. 2011 Feb;22(1):19-33
– reference: 6771077 - Clin Exp Immunol. 1980 Feb;39(2):455-60
– reference: 12499438 - J Clin Pathol. 2003 Jan;56(1):64-8
– reference: 21653326 - Blood. 2011 Aug 4;118(5):e16-31
– reference: 16794250 - Blood. 2006 Oct 15;108(8):2520-30
– reference: 20212186 - Arch Intern Med. 2010 Mar 8;170(5):478-84
– reference: 16571879 - N Engl J Med. 2006 Mar 30;354(13):1362-9
– reference: 20943670 - Eur Heart J. 2011 Jan;32(1):84-92
– reference: 16469089 - J Dermatol. 2006 Jan;33(1):64-7
– reference: 21757618 - Blood. 2011 Oct 6;118(14):3777-84
– reference: 22510809 - Curr Opin Lipidol. 2012 Aug;23(4):377-85
– reference: 21527752 - Arterioscler Thromb Vasc Biol. 2011 Jul;31(7):1675-81
– reference: 21194787 - Eur J Cell Biol. 2011 Jun-Jul;90(6-7):527-35
– reference: 21752713 - Trends Immunol. 2011 Aug;32(8):380-7
– reference: 17475889 - J Immunol. 2007 May 15;178(10):6581-9
– reference: 3096220 - Arch Dermatol. 1986 Nov;122(11):1253-7
– reference: 20702809 - Arterioscler Thromb Vasc Biol. 2010 Sep;30(9):1773-8
– reference: 21803849 - Blood. 2011 Sep 22;118(12):e50-61
– reference: 18952503 - Clin Immunol. 2009 Mar;130(3):338-46
– reference: 21757719 - J Biol Chem. 2011 Sep 2;286(35):30926-36
– reference: 19843579 - J Leukoc Biol. 2010 Apr;87(4):557-67
– reference: 21226578 - N Engl J Med. 2011 Jan 13;364(2):127-35
– reference: 19921193 - Ann Hematol. 2010 Jun;89(6):569-77
– reference: 19729607 - Arterioscler Thromb Vasc Biol. 2009 Nov;29(11):1930-6
– reference: 19126043 - Int J Dermatol. 2009 Jan;48(1):1-10
– reference: 24092747 - Arterioscler Thromb Vasc Biol. 2013 Dec;33(12):2715-23
SSID ssj0013060
Score 2.2770548
Snippet Rationale Xanthomatosis associated with monoclonal gammopathy includes hyperlipidaemic xanthoma (HX), normolipidaemic xanthoma (NX) and necrobiotic...
Xanthomatosis associated with monoclonal gammopathy includes hyperlipidaemic xanthoma (HX), normolipidaemic xanthoma (NX) and necrobiotic xanthogranuloma...
SourceID pubmedcentral
hal
proquest
pubmed
crossref
wiley
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 269
SubjectTerms Aged
Aged, 80 and over
Case-Control Studies
Cholesterol, HDL - metabolism
Cytokines - metabolism
Enzyme-Linked Immunosorbent Assay
Female
HDL
histiocytes
Humans
immune complex
Immunoglobulin G - metabolism
Inflammation - metabolism
Leukocytes, Mononuclear - metabolism
Life Sciences
Lipid Metabolism - physiology
Macrophages - metabolism
Male
Middle Aged
monoclonal immunoglobulin
monocyte
necrobiotic xanthogranuloma
Necrobiotic Xanthogranuloma - etiology
Necrobiotic Xanthogranuloma - metabolism
Original
Paraproteinemias - etiology
Paraproteinemias - metabolism
Phenotype
Title Physiopathology of necrobiotic xanthogranuloma with monoclonal gammopathy
URI https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fjoim.12195
https://www.ncbi.nlm.nih.gov/pubmed/24428816
https://www.proquest.com/docview/1553104997
https://hal.science/hal-03624912
https://pubmed.ncbi.nlm.nih.gov/PMC4279948
Volume 276
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVBFR
  databaseName: Free Medical Journals
  customDbUrl:
  eissn: 1365-2796
  dateEnd: 20231001
  omitProxy: true
  ssIdentifier: ssj0013060
  issn: 0954-6820
  databaseCode: DIK
  dateStart: 19970101
  isFulltext: true
  titleUrlDefault: http://www.freemedicaljournals.com
  providerName: Flying Publisher
– providerCode: PRVWIB
  databaseName: Wiley Online Library - Core collection (SURFmarket)
  issn: 0954-6820
  databaseCode: DR2
  dateStart: 19970101
  customDbUrl:
  isFulltext: true
  eissn: 1365-2796
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0013060
  providerName: Wiley-Blackwell
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT9wwEB4Bh6oX-gTSBwrQS5GCYq8dx1IvqCpaEJSqKhKXKrIdZ0EsSVV2q7a_vjNONmVLhQS3POy8_E3ms2f8GeBNjqBgpmQJsmWfCJ-SSfk8kdpLW1XCVi5kW3zMhifi4FSeLsC72VyYVh-iH3Ajywj_azJwY6-uG3lzfknaCJpmmLOBDDHaz_xvCCENU4SRQogkQz_XaZOGNJ6-6pw3WjyjXMibRPNmvuR1Hhsc0d4j-Dp7hTb_5GJnOrE77vc_6o73fcfHsNwx1Hi3hdQTWPD1U3hw1MXgn8F-SBptaCnjMCQfN1Vc-1bPCavEPw3pEYzQB07HzaWJaaQ3RrA3bkysPx4ZhD7V_vUcTvY-fHk_TLoFGRInuZCJya3MBkopV5ZZLmzqmEu9E2lufc78QBolNYVyS26MTnGfqbRy1mQ6LwWa-gos1U3t1yDWTlfeZsqagRau4pYCjhVCxXPh0XIjeDtrmMJ1auW0aMa46Hst-G2K8G0i2OrLfms1Ov5bahPbty9AstrD3cOCjpEXF5rxHyyCjVnzF2hnFDwxtW-mVwWtr8Sof6giWG3h0F8LKRJHyGcRqDmgzN1s_kx9fha0vAVXWos8gu2Ag1uevzg43j8KWy_uUvglPESOJ9q0uFewNPk-9a-RR03sOixy8Wk9WM0f3Fgb2A
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1LT9wwEB7xkKAX1PIMfYXCBaRIideO4yOqinbpLu0BJG6R7TgL0pJUwCL498w4IWUFQuKWh51E88h89ow_A-xlaBSJLpII0bKLuIvJpVwWCeWEKUtuSuurLU7S_hk_PhfnbW0OrYVp-CG6CTfyDP-_JgenCennXl5fXhE5ghLzsMhTFpNRM_73fxIh9ouEEUTwKMVI17KT-kKeru9MPJq_oGrIl1DzZcXkcyTrQ9HRR1hpMWR42Cj9E8y5ahWWRm2WfA0Gvqyzps2G_aR5WJdh5RrGJewS3mtiDBhjlJpO6isd0lxsiOZY2wnh8nCs0Tip98M6nB39Ov3Zj9otEyIrGBeRzoxIe1JKWxRpxk1sExs7y-PMuCxxPaGlUJRsLZjWKsbzRMalNTpVWcHRGTdgoaortwWhsqp0JpVG9xS3JTOUEixRmY5xh74VwP6T4HLb8onTthaTvBtXoJBzL-QAdru2_xoWjVdb_UD5dw2I-Lp_OMzpGsVZrhJ2lwSw86SeHD2B0hu6cvX0JqcdkBIawckANht1dc9CEMPQKNMA5IwiZ142e6e6vPBs25xJpXgWwIFX-Rvfnx__GYz80fZ7Gn-H5f7paJgPBye_P8MHRGS8KWL7Agu311P3FVHPrfnmbfsR4D_95w
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT9wwEB7xkFAvpfQZoDR9XFopKMnacSz1goDVLgVaVUXiUkW2YwPqkqB2FwG_vjNONmVLVam95WEncfxN5rNn8hngTY6gSFSZRMiWbcRsTCZl84hLy7VzTDvjsy0Os8ER2zvmx3PwfvovTKMP0U24kWX47zUZ-EXpbht5fXZO2giSz8Miy3B4RZToc_orhhD7f4SRQ7AoQ0fXipP6PJ6u7ow7mj-lZMi7TPNuwuRtIus9UX8Zvk7b0CSgfNucjPWmuflN3vF_G_kA7rcUNdxqMLUCc7Z6CEsHbRD-EQx91mhNaxn7OfmwdmFlG0EnrBJeKRIkOEEnOBnV5yqkqd4Q0V6bEdH-8EQh9qn29WM46u9-2R5E7YoMkeEp45HKNc96QghTllnOdGwSE1vD4lzbPLE9rgSXFMstU6VkjPuJiJ3RKpN5ydDWn8BCVVf2GYTSSGd1JrTqSWZcqini6BArNmUWTTeAt9OOKUwrV06rZoyKbtiC76bw7yaA113Zi0ak44-lXmH_dgVIV3uwtV_QMXLjTCbpZRLAy2n3F2hoFD1Rla0nPwpaYCmhAaII4GkDh-5ayJFSxHwWgJgByszNZs9UZ6dezJulQkqWB_DO4-Avz1_sfRwe-K3Vfyn8ApY-7fSL_eHhhzW4h3yPNSly67Aw_j6xz5FTjfWGN52fYOcdzA
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Physiopathology+of+necrobiotic+xanthogranuloma+with+monoclonal+gammopathy&rft.jtitle=Journal+of+internal+medicine&rft.au=Szalat%2C+R.&rft.au=Pirault%2C+J.&rft.au=Fermand%2C+J.%E2%80%90P.&rft.au=Carri%C3%A9%2C+A.&rft.date=2014-09-01&rft.issn=0954-6820&rft.eissn=1365-2796&rft.volume=276&rft.issue=3&rft.spage=269&rft.epage=284&rft_id=info:doi/10.1111%2Fjoim.12195&rft.externalDBID=n%2Fa&rft.externalDocID=10_1111_joim_12195
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0954-6820&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0954-6820&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0954-6820&client=summon